Therapeutic effect of anti-radiation spray on preventing and treating oral mucositis after hematopoietic stem cell transplantation

doi:10.19439/j.sjos.2026.03.008

Abstract

Abstract: PURPOSE: To explore the clinical efficacy of radiation-resistant liquid wound dressing in preventing and treating oral mucositis (OM) after haematopoietic stem cell transplantation (HSCT). METHODS: A total of 68 patients who developed OM after HSCT at Xuanwu Hospital, Capital Medical University from January 2019 to June 2024 were selected and divided into the control group (n=40, standard oral care) and experimental group (n=28, Kangfu Pen combined with standard oral care) according to the type of intervention methods. The onset time and duration of OM, incidence of OM at different grades, and incidence of dry mouth and other related symptoms were compared between the two groups. Changes in the numerical rating scale (NRS) of pain, serum inflammatory factors [C-reactive protein (CRP) and procalcitonin (PCT)] levels, and body mass index (BMI) were recorded from 3 days before intervention to 21 days after transplantation. RESULTS: The incidence of grade Ⅱ-Ⅳ OM in the experimental group (35.7%) was significantly lower than that in the control group (70.0%, P=0.046); the onset time of OM in the experimental group was significantly later, and the duration was significantly shorter than those in the control group (P<0.001). The incidence of dry mouth in the experimental group (7.2%) was significantly lower than that in the control group (27.5%, P=0.036), and the decrease in BMI was significantly smaller than that in the control group (P<0.001). There were no significant differences in NRS scores, CRP, or PCT levels between the two groups 3 days before intervention (P>0.05); the above indicators in both groups reached the highest values on day 7 after transplantation. The NRS scores, CRP and PCT levels in the experimental group were significantly lower than those in the control group on days 3, 7, 14 and 21 after transplantation (P<0.05). No adverse reactions occurred in either group. CONCLUSIONS: Kangfu Pen is safe and effective in preventing and treating OM after HSCT, and can improve patients' quality of life. Its mechanism of action may be related to inhibiting the expression of inflammatory factors.

Key words: Anti-radiation spray, Hematopoietic stem cell transplantation, Oral mucositis, Inflammatory factors, Pain score

CLC Number:

R781.5

Song Jie, Zhang Qianqian, Ni Jing. Therapeutic effect of anti-radiation spray on preventing and treating oral mucositis after hematopoietic stem cell transplantation[J]. Shanghai Journal of Stomatology, 2026, 35(3): 271-275.

References

[1] Bazinet A, Popradi G.A general practitioner's guide to hematopoietic stem-cell transplantation[J]. Curr Oncol, 2019, 26(3): 187-191.
[2] Xue R, Dai M, Jiang E, et al.Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT[J]. Blood Cancer J, 2025, 15(1): 21.
[3] Guberti M, Botti S, Fusco A, et al.Stem cell transplantation patients receiving a novel oral care protocol for oral mucositis prevention and treatment: patient-reported outcomes and quality of life[J]. Support Care Cancer, 2022, 30(7): 6317-6325.
[4] Al-Rudayni AHM, Gopinath D, Maharajan MK, et al.Impact of oral mucositis on quality of life in patients undergoing oncological treatment: a systematic review[J]. Transl Cancer Res, 2020, 9(4): 3126-3134.
[5] Pai RR, Banerjee S, George LS, et al.Impact of an oral care intervention protocol on oral health outcomes in head and neck cancer patients undergoing radiation or chemoradiation therapy[J]. BMC Oral Health, 2025, 25(1): 539.
[6] Liang J, Peng X, Zhou X, et al.Emerging applications of drug delivery systems in oral infectious diseases prevention and treatment[J]. Molecules, 2020, 25(3): 516.
[7] 曾玉, 邝燕好, 龚攀, 等. 捷克信联合抗辐喷对局部晚期头颈部肿瘤所致急性放射性口炎患者的疗效研究[J]. 中华临床医师杂志(电子版), 2022, 16(5): 415-419.
[8] 张文陆, 宇长青, 王言. 放化疗引起的口腔黏膜炎的病理基础和诊断概况[J]. 医学综述, 2007, 13(18): 1388-1390.
[9] Etiz D, Orhan B, Demirüstü C, et al.Comparison of radiation-induced oral mucositis scoring systems[J]. Tumori, 2002, 88(5): 379-384.
[10] 唐春慧. 抗辐喷对急性放射性口腔黏膜炎防护作用的疗效观察[D]. 大连: 大连医科大学, 2019.
[11] Bulthuis MS, van Gennip L, Bronkhorst EM, et al. The effect of hematopoietic stem cell transplantation on patient-reported subjective oral dryness: a systematic review focusing on prevalence, severity and distress[J]. Support Care Cancer, 2023, 31(8): 449-464.
[12] Aoyama T, Notsu A, Ichimaru K, et al.Impact of body mass index on 5-year survival rates in patients undergoing allogeneic hematopoietic stem cell transplantation[J]. Nutr Metab Insights, 2022, 15: 1528491690.
[13] Zhou H, Lin X.Oral mucosal diseases and psychosocial factors: progress in related neurobiological mechanisms[J]. J Int Med Res, 2023, 51(12): 3000605231218619.
[14] Agholme MB, Dahllöf G, Törlén JK, et al.Incidence, severity, and temporal development of oral complications in pediatric allogeneic hematopoietic stem cell transplant patients-a multicenter study[J]. Support Care Cancer, 2023, 31(12): 702.
[15] Liu S, Zhao Q, Zheng Z, et al.Status of treatment and prophylaxis for radiation-induced oral mucositis in patients with head and neck cancer[J]. Front Oncol, 2021, 11: 642575.
[16] Ali S, Zehra A, Khalid MU, et al.Role of C-reactive protein in disease progression, diagnosis and management[J]. Discoveries (Craiova), 2023, 11(4): e179.
[17] Khanna DK, Jayalakshmi KMD, Arun D, et al.A short-term cross-sectional retrospective study on procalcitonin as a diagnostic aid for various infectious diseases[J]. Future J Pharm Sci, 2025, 11: 29.
[18] Sun Y, Aliyari SR, Parvatiyar K, et al.STING directly interacts with PAR to promote apoptosis upon acute ionizing radiation-mediated DNA damage[J]. Cell Death Differ, 2025, 32(6): 1167-1179.
[19] Gebri E, Kiss A, Tóth F, et al.Salivary osteopontin as a potential biomarker for oral mucositis[J]. Metabolites, 2021, 11(4): 208.